Developing vaccines against epidemic-prone emerging infectious diseases
نویسندگان
چکیده
منابع مشابه
New Vaccines against Epidemic Infectious Diseases.
conditions.1-3 Governments and foundations mobilized funds quickly. Companies and research-anddevelopment institutions brought vaccine candidates into the field. Collaborations among the World Health Organization (WHO), funders, academia, civil society, and industry saw vaccines advancing through more than 15 accelerated clinical trials in a year. But the testing of Ebola vaccine candidates had...
متن کاملSelf-disseminating vaccines for emerging infectious diseases
Modern human activity fueled by economic development is profoundly altering our relationship with microorganisms. This altered interaction with microbes is believed to be the major driving force behind the increased rate of emerging infectious diseases from animals. The spate of recent infectious disease outbreaks, including Ebola virus disease and Middle East respiratory syndrome, emphasize th...
متن کاملAAV Vectors Vaccines Against Infectious Diseases
Since their discovery as a tool for gene transfer, vectors derived from the adeno-associated virus (AAV) have been used for gene therapy applications and attracted scientist to this field for their exceptional properties of efficiency of in vivo gene transfer and the level and duration of transgene expression. For many years, AAVs have been considered as low immunogenic vectors due to their abi...
متن کاملAddressing sex and gender in epidemic-prone infectious diseases
Acknowledgements WHO would like to thank Martha Anker for preparing this publication. Thanks are also due to Addressing sex and gender in epidemic-prone infectious diseases. " This publication has been a joint effort of the Departments of Gender, Women and Health, and Epidemic and Pandemic Alert and Response, WHO, Geneva " – Acknowledgements. The designations employed and the presentation of th...
متن کاملVaccines for mucosal immunity to combat emerging infectious diseases.
The mucosal immune system consists of molecules, cells, and organized lymphoid structures intended to provide immunity to pathogens that impinge upon mucosal surfaces. Mucosal infection by intracellular pathogens results in the induction of cell- mediated immunity, as manifested by CD4-positive (CD4 + ) T helper-type 1 cells, as well as CD8 + cytotoxic T-lymphocytes. These responses are normall...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
سال: 2019
ISSN: 1436-9990,1437-1588
DOI: 10.1007/s00103-019-03061-2